Skip to main content

Table 2 Evaluation of the pathogenic potential of PKD genes missense variants

From: Novel mutations of PKD genes in Chinese patients suffering from autosomal dominant polycystic kidney disease and seeking assisted reproduction

cDNA change

Exon

Amino acid change

Co-occurence

SIFT

PolyPhen-2

Mutation Taster

Family No.

Family history

Segregation

Known/Novel

Classification

PKD1

 c.1385G>T

6

p.Arg462Met

 

NT

PRD

D

77

Yes

Yes

Novel

LP

 c.2039A > T

10

p.Tyr680Phe

p.Tyr1879*

NT

POD

P

20

Yes

Yes

Known

LB

 c.2180 T>C

11

p.Leu727Pro

 

NT

PRD

D

69

Yes

Yes

Known

LP

 c.2897G>C

12

p.Arg966Pro

 

NT

PRD

D

73

Yes

Yes

Novel

LP

 c.3548C > G

15

p.Ser1183Trp

p.Gln1653*

NT

B

P

16

Yes

Yes

Novel

LB

 c.3613G>C

15

p.Asp1205His

 

NT

POD

P

64

Yes

Yes

Novel

LP

76

No

NA

 c.3868C > G

15

p.Leu1290Val

p.Gln1653*

T

B

P

16

Yes

Yes

Novel

LB

 c.3931G>A

15

p.Ala1311Thr

 

NT

B

P

80

No

No

Known

LB

 c.4273C > T

15

p.Arg1425Cys

p.Gln3838*

NT

B

P

15

Yes

Yes

Novel

LB

 c.5600A > G

15

p.Asn1867Ser

p.Arg400*

NT

PRD

D

17

Yes

Yes

Novel

USV

 c.5957C>T

15

p.Thr1986Met

 

NT

PRD

P

87

Yes

NA

Novel

LB

 c.6658C>T

15

p.Arg2220Trp

 

NT

PRD

D

85

Yes

Yes

Known

LP

 c.6704C>T

15

p.Ser2235Leu

 

NT

PRD

D

70

Yes

Yes

Novel

LP

 c.6827 T>C

15

p.Leu2276Pro

 

NT

PRD

D

61

Yes

Yes

Known

LP

 c.6878C > T

15

p.Pro2293Leu

p.Pro36Leufs*78

NT

POD

P

12

Yes

NA

Known

LB

 c.7099 T>C

17

p.Ser2367Pro

 

NT

PRD

D

56

Yes

NA

Novel

LP

 c.7144A>C

17

p.Ser2382Arg

 

NT

PRD

D

67

Yes

Yes

Novel

LP

 c.7241C > T

18

p.Thr2414Met

c.11269 + 1G > A

NT

PRD

D

10

Yes

Yes

Known

LP

 c.7589G>A

19

p.Gly2530Asp

 

NT

PRD

D

59

No

NA

Known

LP

 c.8158A>C

22

p.Thr2720Pro

 

NT

PRD

D

86

NA

NA

Novel

LP

 c.8311G>A

23

p.Glu2771Lys

 

NT

PRD

D

83

Yes

NA

Known

LP

 c.8744A > G

23

p.Asn2915Ser

p.Ser4190Serfs*21

T

B

D

28

Yes

Yes

Novel

USV

 c.8750C > T

23

p.Ala2917Val

p.Gln3838*

T

POD

P

15

Yes

Yes

Known

LB

p.Gln1653*

16

Yes

Yes

 c.10937 T>G

37

p.Val3646Gly

 

T

PRD

D

68

Yes

Yes

Novel

LP

 c.10951G>A

37

p.Gly3651Ser

 

T

PRD

D

79

Yes

NA

Known

LP

 c.11156G>T

38

p.Arg3719Leu

 

NT

PRD

D

82

Yes

Yes

Novel

LP

 c.11248C>G

39

p.Arg3750Gly

 

NT

PRD

D

74

No

Yes

Known

LP

 c.11257C>T

39

p.Arg3753Trp

 

NT

PRD

D

84

Yes

Yes

Known

LP

 c.11351G > T

40

p.Gly3784Val

 

T

B

P

75

Yes

Yes

Novel

LB

 c.11453G>A

41

p.Gly3818Asp

 

NT

PRD

D

81

Yes

Yes

Known

LP

 c.11945A>C

43

p.Gln3982Pro

 

NT

PRD

P

78

Yes

Yes

Novel

LP

 c.12671C>A

46

p.Thr4224Asn

 

NT

POD

P

66

Yes

NA

Novel

USV

PKD2

 c.965G>A

4

p.Arg322Gln

 

NT

PRD

D

64

Yes

NA

Known

LP

GANAB

 c.518G>A

5

p.Arg173Gln

 

T

PRD

D

58

Yes

NA

Novel

B

86

NA

NA

 c.991C>T

10

p.Arg331Cys

 

NT

PRD

D

61

Yes

No

Novel

LB

 c.1078A>G

11

p.Met360Val

 

NT

B

D

62

Yes

NA

Novel

USV

 c.367C>G

4

p.Pro123Ala

 

T

POD

D

69

Yes

Yes

Novel

USV

 c.2292A>G

19

p.Ile764Met

 

T

B

D

Yes

Novel

USV

  1. NT Not Tolerated, T Tolerated, PRD Probably damaging, B Benign, POD Possibly damaging, D Disease causing, P Polymorphism, LB likely benign variation, LP likely pathogenic variation, USV uncertain significance variation, NA not available, *translation termination codon